We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current REDX market cap is 47.65M. The company's latest EPS is GBP -0.0852 and P/E is -1.44.
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 3.13M | 5.69M | 10.04M | 18.69M | 4.2M |
| Operating Income | -6.16M | -6.95M | -18.06M | -16.2M | -31.76M |
| Net Income | -4.32M | -9.21M | -21.58M | -18.01M | -33.16M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 6.36M | 32.93M | 39.55M | 62.48M | 25.64M |
| Total Liabilities | 4.87M | 30.9M | 26.41M | 29.16M | 22.28M |
| Total Equity | 1.49M | 2.03M | 13.13M | 33.32M | 3.36M |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -4.67M | 395k | -21.38M | -8.47M | -34.75M |
| Investing | 32k | -55k | -754k | -241k | -195k |
| Financing | 1.87M | 23.47M | 24.14M | 32.98M | -816k |
| Market Cap | 47.65M |
| Price to Earnings Ratio | -1.44 |
| Price to Sales Ratio | 11.34 |
| Price to Cash Ratio | 2.63 |
| Price to Book Ratio | 14.2 |
| Dividend Yield | - |
| Shares Outstanding | 388.99M |
| Average Volume (1 week) | 629.27k |
| Average Volume (1 Month) | 2.13M |
| 52 Week Change | -61.11% |
| 52 Week High | 36.00 |
| 52 Week Low | 4.25 |
| Spread (Intraday) | 1.5 (11.54%) |
| Company Name | Redx Pharma Plc |
| Address |
block 33 cheshire SK10 4TG |
| Website | https://www.redxpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
